Institution
Anthony Nolan
Nonprofit•London, England, United Kingdom•
About: Anthony Nolan is a nonprofit organization based out in London, England, United Kingdom. It is known for research contribution in the topics: Transplantation & Human leukocyte antigen. The organization has 230 authors who have published 272 publications receiving 13641 citations.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: A survey of new volunteer donor typing among WMDA member registries has identified the methods and resolution of HLA testing and the level of quality control used to evaluate the accuracy of typing results.
Abstract: Over 10 million volunteer donors and cord blood units are typed for human leukocyte antigen (HLA) within hematopoietic stem cell registries and cord blood banks. Identification of matched donors in countries different from that of the searching patient is facilitated by Bone Marrow Donors Worldwide and the World Marrow Donor Association (WMDA). A survey of new volunteer donor typing among WMDA member registries has identified the methods and resolution of HLA testing and the level of quality control used to evaluate the accuracy of typing results. The diversity of HLA assignments within registries has generated a number of informatics challenges. Registries are using population genetics to enhance registry diversity and to facilitate the identification of matched donors.
24 citations
••
University of Minnesota1, Medical College of Wisconsin2, Children's Hospital Oakland3, Center for International Blood and Marrow Transplant Research4, Washington University in St. Louis5, Fred Hutchinson Cancer Research Center6, Ohio State University7, Roswell Park Cancer Institute8, Emory University9, Cleveland Clinic10, Stanford University11, Anthony Nolan12
TL;DR: Evaluated AML searches from 14 participating centers with centralized donor KIR genotyping for donor selection found that choosing more donors per search would substantially increase the likelihood of having a KIR best or better donor available for transplantation.
24 citations
••
TL;DR: In this paper, the authors used HLA-A as a model to illustrate factors that are barriers to delineating the relationship between specific HLA mismatches and transplant outcomes in the United States.
24 citations
••
TL;DR: This modified nomenclature system is essential to maintain the current functionality of IPD-MHC and provide a scalable future-proof database organisation to fully exploit the bioinformatic tools used for analysis.
Abstract: The IPD-MHC Database is the official repository for non-human MHC sequences, overseen and supported by the Comparative MHC Nomenclature Committee, providing access to curated MHC data and associated analysis tools. To address the increasing amount and complexity of data being submitted, an entirely upgraded version of the IPD-MHC Database was recently released to maintain IPD-MHC as the central platform for the comparison of curated MHC data. As a consequence, a new level of nomenclature standardisation is required between the different species to enable data submission and to allow the unambiguous inter- and intra-species comparison of alleles. However, any changes must retain the flexibility demanded by the unique biology of different taxonomic groups. Here, we describe the rationale for a standardised nomenclature system and summarise the changes that have been driven by the requirements of implementing the IPD-MHC database. This modified nomenclature system is essential to maintain the current functionality of IPD-MHC and provide a scalable future-proof database organisation to fully exploit the bioinformatic tools used for analysis.
24 citations
••
TL;DR: Active investigation is in progress in seven key areas: the impact of HLA matching, role of race and ethnicity, identification of permissible HLA mismatches, haplotype‐associated determinants, minor histocompatibility antigens, immune response genes and KIR genetics.
Abstract: The International Histocompatibility Working Group is a collaborative international effort to understand the HLA and non-HLA genetics of the transplantation barrier. The Working Group is comprised of experts in the fields of histocompatibility and immunogenetics, hematopoietic cell transplantation and outcomes research. Data for 25 855 unrelated donor transplants were submitted in support of research studies for the 16th International Histocompatibility Workshop. Active investigation is in progress in seven key areas: the impact of HLA matching, role of race and ethnicity, identification of permissible HLA mismatches, haplotype-associated determinants, minor histocompatibility antigens, immune response genes and KIR genetics. New hypotheses for the 16th workshop were developed for immunogenetic studies in cord blood and haploidentical-related donor transplantation.
23 citations
Authors
Showing all 236 results
Name | H-index | Papers | Citations |
---|---|---|---|
Ghulam J. Mufti | 88 | 687 | 30934 |
Nigel H. Russell | 76 | 502 | 21810 |
Steven G.E. Marsh | 65 | 487 | 20763 |
Frits van Rhee | 61 | 323 | 14983 |
Charles Craddock | 60 | 302 | 13660 |
James Robinson | 48 | 172 | 11429 |
John Barrett | 44 | 114 | 7428 |
Bronwen E. Shaw | 42 | 286 | 6191 |
Richard Szydlo | 41 | 166 | 4775 |
Nancy F. Hensel | 34 | 87 | 4754 |
Alejandro Madrigal | 29 | 101 | 3529 |
Lawrence S. Lamb | 28 | 88 | 2311 |
Susana Gómez | 27 | 69 | 1891 |
Ann-Margaret Little | 26 | 63 | 2443 |
J. Alejandro Madrigal | 26 | 105 | 2577 |